CryoLife acquires 8% stake in Medafor - MarketLine Financial Deals

CryoLife acquires 8% stake in Medafor

CryoLife acquires 8% stake in Medafor - MarketLine Financial Deals
CryoLife acquires 8% stake in Medafor
Published Jan 13, 2010
1 pages — Published Jan 13, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

CryoLife, Inc. has acquired approximately 8% stake in Medafor, Inc., a medical device technology company, from Medafor's founders and certain shareholders.

  
Source:
Document ID
MA18432_100203
Country
Ticker
CRY=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "CryoLife acquires 8% stake in Medafor" Jan 13, 2010. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/CryoLife-acquires-8-stake-in-Medafor-2052-23103>
  
APA:
MarketLine Financial Deals. (2010). CryoLife acquires 8% stake in Medafor Jan 13, 2010. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/CryoLife-acquires-8-stake-in-Medafor-2052-23103>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.